【臨床試驗】根據細胞與人體在「藥物標靶干擾」差異，改進「臨床試驗」藥物批准預測

 【臨床試驗】根據細胞與人體在「藥物標靶干擾」差異，改進「臨床試驗」藥物批准預測

 文章出處  

  EBioMedicine

 

 原文標題  

 Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humans

 

 文章序號  

 4261

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.